Stock Performance - Several stocks related to deep-sea technology have shown significant gains, with Deepwater Haina leading at 20.00% increase, followed by other companies like Zhenhua Heavy Industry at 10.00% and Shenkai Co. at 10.01% [2][3][4] - In the photovoltaic sector, stocks such as Yao Pi Glass and Euro Crystal Technology have also performed well, with increases of 9.93% and 10.02% respectively [5][6] - The steel industry has seen a turnaround, with companies like Liugang Co. and Chongqing Steel achieving gains of 10.08% and 10.16% respectively [7][8] Industry Trends - The photovoltaic glass industry is experiencing a collective production cut of 30% starting from July, which is expected to reduce domestic glass output to approximately 45GW [4] - The nuclear power sector is gaining attention due to a significant agreement between Alphabet and a fusion energy company, marking a milestone in commercial power procurement [10] - The wind power sector is projected to grow rapidly, with offshore wind capacity expected to exceed 230GW globally by 2030, positioning China's deep-sea projects as key growth points [18] Emerging Opportunities - The innovative drug sector is supported by new measures from the National Healthcare Security Administration, which aims to include innovative drugs in basic medical insurance [16][17] - The sugar substitute market is expanding, with the approval of a new production company for allulose sugar, indicating potential growth in this niche [14][15] - The military industry is expected to see an increase in orders, reversing a downward trend, which could lead to positive growth in the second half of the year [20][21]

Core Insights - Dr. Peng Junren from Dineike's Brain-Computer Interface (BCI) division published a paper in the "Annals of the New York Academy of Sciences" discussing a new approach to shared autonomy between human electroencephalography and TD3 deep reinforcement learning [1] - The study indicates that approximately 15%-30% of users are unable to effectively operate traditional BCI systems due to physiological differences, highlighting a gap in current technology that only measures internal brain activity without considering environmental factors [1] - Dineike's BCI division proposes an active BCI co-control scheme based on deep reinforcement learning, aiming to provide a new paradigm for the universal application of BCIs through collaborative decision-making between humans and AI agents [1] - The next steps for Dineike involve focusing on breakthroughs in core technologies related to brainwave interaction and the industrialization of these technologies, moving from laboratory research to practical applications [1]

Summary of Neural Interface Industry Developments Industry Overview - The neural interface industry is experiencing significant advancements both domestically and internationally, with companies like Neuralink leading the way in invasive brain-machine interface (BMI) technology [1][2][29]. Key Developments and Core Insights - **Neuralink's Progress**: Neuralink has successfully implanted brain-machine interfaces in seven patients, including the first overseas case. Initial issues with signal degradation were resolved through software adjustments, but long-term stability remains to be observed [1][3]. - **Technological Pathways**: Neuralink's technology is inspired by deep brain stimulation (DBS) and aims to treat various neurological disorders. The company plans to achieve full brain implantation by 2028, targeting areas for emotional regulation and mental health treatment [1][4][5]. - **Commercialization Timeline**: The commercialization of invasive BMIs is expected to take until 2028-2030 due to challenges such as clinical evaluations, device approvals, and patient availability. Non-invasive technologies are already being commercialized, with approval from the National Healthcare Security Administration for rehabilitation training systems [1][9][7]. - **Non-Invasive Technology**: Non-invasive BMIs primarily use electrodes, chips, and amplifier modules. The accuracy of signal collection and transmission quality is crucial, with consumer-grade devices having lower sampling rates compared to high-end imported products [1][18][19]. Challenges and Considerations - **Technical Challenges**: Neuralink faces challenges such as signal degradation and electrode displacement in patients, which may affect long-term functionality. Continuous monitoring is required to ensure stability over extended periods [3][29]. - **Algorithm Development**: Algorithms are critical in BMI systems, but domestic companies often use closed data collection methods, limiting the universality of their algorithms. In contrast, international firms like Neuralink adopt more open approaches to enhance performance through data sharing [31]. Regulatory and Standardization Efforts - **New Standards**: The government has introduced new standards for data sets and hardware products in the neural interface sector, focusing on sampling rates, consistency, noise levels, and transmission stability [26][27]. - **Clinical Application**: Hospitals across China are beginning to establish clinics for neural interface research, indicating a push towards integrating this technology into medical practice [30]. Market Dynamics and Competitive Landscape - **Emerging Companies**: Several domestic companies are making strides in the non-invasive BMI sector, such as Qiangnao Technology, which focuses on attention training for children with autism and ADHD [10][15]. - **International Competitors**: Companies like Muse and New Sky are developing portable consumer-grade non-invasive devices, while Neuralink continues to lead in invasive technology [15][17]. Future Outlook - **Technological Integration**: The potential for integrating AI with human capabilities through implanted chips is being explored, with implications for enhancing cognitive functions and addressing challenges posed by AI advancements [6][5]. - **Market Expansion**: Non-invasive BMIs are expected to expand into major hospitals within the next 2-3 years, with broader commercialization anticipated in 3-5 years [9][20]. Conclusion The neural interface industry is on the cusp of transformative developments, with significant investments in technology, regulatory frameworks, and clinical applications. The interplay between invasive and non-invasive technologies will shape the future landscape of this innovative field.

Core Insights - Neuralink has showcased its brain-computer interface (BCI) advancements and a visionary roadmap for the next three years, indicating significant progress in BCI technology [1] - The company aims to create a full-brain interface that can decode brain signals into speech, restore vision, and potentially integrate human consciousness with AI by 2028 [3][4] Group 1: Current Achievements - Seven volunteers have undergone the N1 implant surgery, enabling them to interact with the world despite severe disabilities [2] - The technology focuses on increasing the number of connected neurons and expanding to any part of the brain, enhancing the amount of information that can flow from the brain to the external world [2] Group 2: Future Goals - By Q4 2025, Neuralink plans to implant devices that can decode words from brain signals [3] - The number of electrodes is expected to increase to 3,000 by 2026, allowing the first blind participants to regain vision [3] - By 2028, the goal is to have over 25,000 channels per implant, enabling access to any part of the brain and addressing various mental health issues [3] Group 3: Challenges and Concerns - There are significant technical challenges and skepticism from neuroscientists regarding the feasibility of achieving a full-brain interface by 2028 [4] - Data privacy and security concerns are paramount, as the sensitivity of brainwave data raises questions about potential misuse [4] - The impact of this technology on individual identity and self-perception remains uncertain, prompting discussions on its societal implications [5]

7月1日，脑机接口概念延续强势，创新医疗2连板，塞力医疗涨停，翔宇医疗涨超5%，爱朋医疗、三博 脑科、伟思医疗等跟涨。 消息面上，中国首个脑机接口未来产业集聚区"脑智天地"在上海启动建设。另外，马斯克在脑机接口 Neuralink团队的发布会上表示，目前全球已经有七人植入了设备，通过"心灵感应"产品，他们重获跟物 理世界交互的能力，可以用大脑玩马里奥赛车、使命召唤，甚至可以控制机械臂写字。预计2026年让盲 人重获光明，2028年计划实现更广泛的人机融合应用。 国家药监局于6月20日审议通过《关于优化全生命周期监管支持高端医疗器械创新发展的举措》。其中 提到，加快发布医用外骨骼机器人、放射性核素成像设备等相关标准；积极筹建医用机器人、人工智能 医疗器械标准化技术委员会；加强增材制造用医用材料、脑机接口柔性电极、基因工程合成生物材料等 新型生物材料标准化研究。 东吴证券表示，侵入式技术的持续突破将推动消费和医疗康复市场提升对脑机接口技术的认知，非侵入 式脑机接口产品的商业化落地也有望加速。此外，前沿探索如生物计算机等领域的发展，也为脑机接口 技术的未来发展提供了更多可能性。浙商证券表示，脑科学如能取得重大进展， ...

Investment Rating - The report maintains a "Positive" investment rating for the industry [7]. Core Insights - The computer sector experienced a significant increase of 8.18% last week, outperforming the overall market, which rose by 1.91% [2][4]. - The report highlights the active interest in stablecoins and financial IT concepts, particularly following regulatory developments in Hong Kong [6][49]. - Key recommendations include focusing on companies with issuance qualifications, those with technological expertise in blockchain, and firms holding relevant licenses [6][49]. Summary by Sections Market Performance - The computer sector ranked first among major industries, with a trading volume accounting for 12.44% of the total market [4][12]. - Notable stocks in the sector included Tianli Technology (+58.40%), Jingbeifang (+39.90%), and others, reflecting strong performance in financial IT and stablecoin-related themes [14][15]. Stablecoin Focus - The Hong Kong government has approved regulations to enhance the trading of virtual assets, including stablecoins, which are expected to grow rapidly [6][38]. - As of May 1, 2025, the total market size of stablecoins reached approximately $227.37 billion, marking a year-on-year growth of 46.5% [38][40]. - Stablecoins are increasingly being utilized in cross-border remittances, offering faster and cheaper transactions compared to traditional methods [44]. Technological Developments - Tesla's Robotaxi service has launched, potentially accelerating the commercialization of autonomous taxi services [17][25]. - Neuralink has made significant advancements in brain-machine interface technology, showcasing its potential to improve the quality of life for individuals with disabilities [26][35].

脑机接口(BCI)无疑是当下最热门的前沿科技话题之一。近日，马斯克旗下脑机接口公司Neuralink展示他们最新的研 究进展，将各界对这一话题的讨论推向新的高潮。 脑机接口亟需科学界、产业界及国家战略层面的协同关注与投入 在此背景下，6月30日上午，在位于河套深港科技创新合作区的深圳创新发展研究院"院士报告厅"，中国科学院院 士、南京大学副校长郑海荣，为观众做了一场"脑机接口与生物智能"的演讲。 郑海荣认为，脑机接口是掌握未来人工智能最高形态的重要抓手，也是解决未来重大医疗需求的关键路径。基于其兼 具变革性与颠覆性的双重特征，亟需科学界、产业界及国家战略层面的协同关注与投入。 最需要脑机接口的领域 "人类大脑就是一个生物的宇宙，我们外面是一个物理的宇宙。如何把生物的宇宙和物理的宇宙连接起来，这是重要 的科学命题。"郑海荣说。 他以科幻电影《阿凡达》中通过意念驾驭飞龙的场景为引，阐释了脑机接口技术"读取"大脑神经信号并"写入"反馈指 令以实现控制的核心原理。 郑海荣指出，当前脑机接口研究的核心目标之一，是深入解析大脑的功能特征，尤其是与疾病相关的神经机制。例 如，通过植入式装置，有望帮助中风患者或失明人士重建因 ...

Investment Rating - The report maintains a "Positive" investment rating for the industry [5]. Core Insights - Neuralink, a leading brain-computer interface company, showcased significant advancements in its technology, indicating a potential acceleration in the commercialization of brain-computer interfaces [2][10]. - The report suggests focusing on three main investment themes: 1) domestic mapping of the advanced overseas invasive brain-computer interface supply chain; 2) product deployment of non-invasive brain-computer interfaces in consumer scenarios; 3) downstream application targets related to brain-computer interfaces [10]. Summary by Sections Event Description - On June 27, Neuralink released a one-hour video demonstrating its latest research achievements and product development directions [3]. Event Commentary - The report highlights the impressive progress of Neuralink's brain-computer interface technology, which has significantly improved the quality of life for its seven trial participants, including patients with spinal cord injuries and ALS [10]. - Future plans include the development of a "full brain interface" with milestones set for 2025 to 2027, aiming to decode conscious speech and restore vision [10]. Product Overview - Neuralink currently has three products targeting different scenarios: 1) "Telepathy" for patients with motor disabilities; 2) "Blindsight" for visually impaired individuals; 3) "Deep" for neurological disorders [10].

Core Viewpoint - The article emphasizes the need to explore non-invasive brain-computer interface (BCI) technologies rather than invasive methods, as proposed by Chinese Academy of Sciences academician Zheng Hairong [2][3][9]. Industry Overview - The global BCI market is projected to grow from $2.35 billion in 2023 to $10.89 billion by 2033, indicating significant investment and interest in this sector [5]. - Major players in the BCI field include Neuralink, which focuses on invasive methods, and Synchron, which has developed a less invasive approach with support from tech giants like Apple and NVIDIA [2][7]. Technological Developments - Neuralink has reported advancements in its invasive BCI technology, with patients able to control complex devices using their thoughts, showcasing a leap from simple cursor control to intricate robotic manipulation [5][6]. - Synchron has achieved key safety milestones with its BCI devices, including FDA approval for temporary implants and successful long-term trials without severe adverse events [8]. Critique of Current Approaches - Zheng Hairong criticizes the invasive methods as "brute force engineering," arguing that they fail to understand the complexity of the human brain and its evolutionary history [3][9]. - He highlights the challenges of biological compatibility in invasive BCIs, noting that many electrodes fail due to the brain's natural resistance [6]. Alternative Approaches - Zheng advocates for a non-invasive approach that utilizes external technologies like ultrasound and fMRI to read and potentially write brain signals without penetrating the skull [9][10]. - This method aims to decode brain activity by observing the relationship between blood flow and neural activity, likening it to a soldier and their supplies [10]. Future of AI and BCI - Zheng outlines a three-stage evolution of AI, with the final stage being "biological intelligence" achieved through effective BCI integration [12][13]. - He envisions a future where hospitals transform into AI-driven data centers, moving away from traditional medical practices [14]. Ethical Considerations - The article raises concerns about the ethical implications of BCI technology, emphasizing the need for strong regulations to prevent misuse and ensure human control over technology [14][15]. - Global legislative efforts are underway to protect brain data, indicating a growing recognition of the ethical challenges posed by BCI advancements [15]. Timeline for Adoption - Zheng estimates that it may take 20 to 30 years for BCI technology to become a part of everyday life for the general public [17].

Core Viewpoint - The global brain-computer interface (BCI) sector is experiencing significant advancements, with companies like Neuralink and Synchron leading the way in different technological approaches [2][4][6] Group 1: Company Developments - Neuralink has increased its number of human trial participants to 7 and demonstrated the ability to control a robotic arm using thoughts [2] - Synchron has achieved native integration with Apple devices through a new protocol, enhancing its market presence [2] - Precision Neuroscience received FDA approval for a temporary implantable device, marking a step towards commercialization [6] Group 2: Market Growth - The global BCI market is projected to grow from $2.35 billion in 2023 to $10.89 billion by 2033, indicating a substantial increase in investment and interest [4] Group 3: Technological Approaches - Two main technological paths are identified: invasive methods like those used by Neuralink, which require surgical implantation, and less invasive methods like those of Synchron, which utilize blood vessels for sensor delivery [2][6] - The invasive approach has shown promising results, allowing patients to perform complex tasks, but faces challenges related to biological compatibility [5][6] Group 4: Alternative Perspectives - Chinese Academy of Sciences academician Zheng Hairong advocates for non-invasive BCI technologies, arguing that current invasive methods are outdated and lack imagination [3][8] - Zheng proposes using external physical methods like ultrasound and fMRI to read and potentially write brain information without surgical intervention [8][9] Group 5: Future Implications - Zheng predicts that the future of AI will involve a three-stage evolution, culminating in "biological intelligence" achieved through effective brain-computer integration [10][11] - He envisions a healthcare system transformed by AI, moving away from traditional methods to a data-centric model that predicts and manages diseases [12] Group 6: Ethical Considerations - The ethical implications of BCI technology are becoming a global concern, with countries like Chile and Colorado taking legislative steps to protect brain data [13] - Zheng emphasizes the need for strong regulations to ensure that brain-computer interfaces remain under human control, highlighting the potential risks of losing that control [12][13] Group 7: Timeline for Adoption - Zheng estimates that it may take 20 to 30 years for BCI technology to become a part of everyday life for the general public [14]